Market Cap (In EUR)
511.14 Million
Revenue (In EUR)
101.03 Million
Net Income (In EUR)
12.83 Million
Avg. Volume
4831.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 44.85-63.5
- PE
- -
- EPS
- -
- Beta Value
- 0.336
- ISIN
- IT0005274094
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Andrea Lacorte
- Employee Count
- -
- Website
- https://www.pharmanutra.it
- Ipo Date
- 2017-07-18
- Details
- Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
More Stocks
-
INDOTECHIndo Tech Transformers Limited
INDOTECH
-
ITSA3Itaúsa S.A.
ITSA3
-
9633
-
BALLBall Corporation
BALL
-
001275BOOKOOK Securities Co., Ltd.
001275
-
SF
-
CRI
-
PBFPBF Energy Inc.
PBF